vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»vsp-1375Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWПОВЫШЕНИЕ КАЧЕСТВА ЖИЗНИ КАК ОСНОВНАЯ ЦЕЛЬ ТЕРАПИИ АЛЛЕРГИЧЕСКОГО РИНИТА У ДЕТЕЙIMPROVEMENT OF QUALITY OF LIFE AS THE MAIN OBJECTIVE OF ALLERGIC RHINITIS THERAPY IN CHILDRENСайгитовР.Т.SaygitovR.T.Научный центр здоровья детей РАМН, МоскваРоссияScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowRussian Federation20082210201572Вопросы современной педиатрии102106Copyright © Сайгитов Р., 20082008Сайгитов Р.Saygitov R.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/1375ReferencesRebok G., Riley A., Forrest C. et al. Elementary school-aged children's reports of their health: a cognitive interviewing study. Qual. Life Res. 2001; 10 (1): 59–70.Rebok G., Riley A., Forrest C. et al. Elementary school-aged children's reports of their health: a cognitive interviewing study. Qual. Life Res. 2001; 10 (1): 59–70.Juniper E.F., Howland W.C., Roberts N.B. et al. Measuring quality of life in children with rhinoconjunctivitis. J. Allergy Clin. Immunol. 1998; 101(2 Pt. 1): 163–170.Juniper E.F., Howland W.C., Roberts N.B. et al. Measuring quality of life in children with rhinoconjunctivitis. J. Allergy Clin. Immunol. 1998; 101(2 Pt. 1): 163–170.Juniper E.F., Guyatt G.H., Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J. Allergy Clin. Immunol. 1994; 93 (2): 413–423.Juniper E.F., Guyatt G.H., Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J. Allergy Clin. Immunol. 1994; 93 (2): 413–423.Juniper E.F. Measuring health-related quality of life in rhinitis. J. Allergy Clin. Immunol. 1997; 99: 742–749.Juniper E.F. Measuring health-related quality of life in rhinitis. J. Allergy Clin. Immunol. 1997; 99: 742–749.Bousquet P.J., Combescure C., Neukirch F. et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007; 62 (4): 367–372.Bousquet P.J., Combescure C., Neukirch F. et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007; 62 (4): 367–372.Bousquet J., Knani J., Dhivert H. et al. Quality of life in asthma, I: internal consistency and validity of the SF-36 questionnaire. Am. J. Respir. Crit. Care Med. 1994; 149: 371–375.Bousquet J., Knani J., Dhivert H. et al. Quality of life in asthma, I: internal consistency and validity of the SF-36 questionnaire. Am. J. Respir. Crit. Care Med. 1994; 149: 371–375.Tanner L.A., Reilly M., Meltzer E.O. et al. Effect of fexofenadine HCl on quality of life and work, classroom, and daily activity impairment in patients with seasonal allergic rhinitis. Am J. Manage Care. 1999; 5: 235–247.Tanner L.A., Reilly M., Meltzer E.O. et al. Effect of fexofenadine HCl on quality of life and work, classroom, and daily activity impairment in patients with seasonal allergic rhinitis. Am J. Manage Care. 1999; 5: 235–247.De Graaf-in 't Veld T., Koenders S., Garrelds I.M., Gerth van Wijk R. The relationships between nasal hyperreactivity, quality of life, and nasal symptoms in patients with perennial allergic rhinitis. J. Allergy Clin. Immunol. 1996; 98 (3): 508–513.De Graaf-in 't Veld T., Koenders S., Garrelds I.M., Gerth van Wijk R. The relationships between nasal hyperreactivity, quality of life, and nasal symptoms in patients with perennial allergic rhinitis. J. Allergy Clin. Immunol. 1996; 98 (3): 508–513.Kay D.J., Rosenfeld R.M. Quality of life for children with persistent sinonasal symptoms. Otolaryngol. Head Neck Surg. 2003; 128 (1): 17–26.Kay D.J., Rosenfeld R.M. Quality of life for children with persistent sinonasal symptoms. Otolaryngol. Head Neck Surg. 2003; 128 (1): 17–26.Braun-Fahrländer C., Wüthrich B., Gassner M. et al. Validation of a rhinitis symptom questionnaire (ISAAC core questions) in a population of Swiss school children visiting the school health services. Pediatr. Allergy Immunol. 1997; 8 (2): 75–82.Braun-Fahrländer C., Wüthrich B., Gassner M. et al. Validation of a rhinitis symptom questionnaire (ISAAC core questions) in a population of Swiss school children visiting the school health services. Pediatr. Allergy Immunol. 1997; 8 (2): 75–82.Juniper E.F., Guyatt G.H. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin. Exp. Allergy. 1991; 21 (1): 77–83.Juniper E.F., Guyatt G.H. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin. Exp. Allergy. 1991; 21 (1): 77–83.Jaeschke R., Singer J., Guyatt G.H. Measurement of health status. Ascertaining the minimal clinically important difference. Control. Clin. Trials. 1989; 10: 407–415.Jaeschke R., Singer J., Guyatt G.H. Measurement of health status. Ascertaining the minimal clinically important difference. Control. Clin. Trials. 1989; 10: 407–415.Lydick E., Epstein R.S. Interpretation of quality of life changes. Qual. Life Res. 1993; 2: 221–226.Lydick E., Epstein R.S. Interpretation of quality of life changes. Qual. Life Res. 1993; 2: 221–226.De Vet H.C., Terwee C.B., Ostelo R.W. et al. Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change. Health Qual. Life Outcomes. 2006; 22: 4–54.De Vet H.C., Terwee C.B., Ostelo R.W. et al. Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change. Health Qual. Life Outcomes. 2006; 22: 4–54.Vuurman E.F., van Veggel L.M., Uiterwijk M.M. et al. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann. Allergy. 1993; 71 (2): 121–126.Vuurman E.F., van Veggel L.M., Uiterwijk M.M. et al. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann. Allergy. 1993; 71 (2): 121–126.Vermeulen J., Mercer M. Comparison of the efficacy and tolerability of topical levocabastine and sodium cromoglycate in the treatment of seasonal allergic rhinoconjunctivitis in children. Pediatr. Allergy Immunol. 1994; 5: 209–213.Vermeulen J., Mercer M. Comparison of the efficacy and tolerability of topical levocabastine and sodium cromoglycate in the treatment of seasonal allergic rhinoconjunctivitis in children. Pediatr. Allergy Immunol. 1994; 5: 209–213.Fowler M.G., Davenport M.G., Garg R. School functioning of US children with asthma. Pediatrics. 1992; 90 (6): 939–944.Fowler M.G., Davenport M.G., Garg R. School functioning of US children with asthma. Pediatrics. 1992; 90 (6): 939–944.Meltzer E.O. Antihistamine and decongestant induced performance decrements. J. Occup. Med. 1990; 32: 327–334.Meltzer E.O. Antihistamine and decongestant induced performance decrements. J. Occup. Med. 1990; 32: 327–334.Malone D.C., Lawson K.A., Smith D.H. et al. A cost of illness study of allergic rhinitis in the United States. J. Allergy Clin. Immunol. 1997; 99(1 Pt. 1): 22–27.Malone D.C., Lawson K.A., Smith D.H. et al. A cost of illness study of allergic rhinitis in the United States. J. Allergy Clin. Immunol. 1997; 99(1 Pt. 1): 22–27.Намазова Л.С., Вознесенская Н.И., Торшхоева Р.М., Эфендиева К.Е. Аллергический ринит. Consilium medicum. 2002; 5 (10): 2–10.Намазова Л.С., Вознесенская Н.И., Торшхоева Р.М., Эфендиева К.Е. Аллергический ринит. Consilium medicum. 2002; 5 (10): 2–10.Richards W. Preventing behavior problems in asthma and allergies. Clin. Pediatr. (Phila) 1994; 33 (10): 617–624.Richards W. Preventing behavior problems in asthma and allergies. Clin. Pediatr. (Phila) 1994; 33 (10): 617–624.Mansour M.E., Kotagal U., Rose B. et al. Health related quality of life in urban elementary schoolchildren. Pediatrics. 2003; 111(6 Pt. 1): 1372–1381.Mansour M.E., Kotagal U., Rose B. et al. Health related quality of life in urban elementary schoolchildren. Pediatrics. 2003; 111(6 Pt. 1): 1372–1381.Simon A.E., Chan K.S., Forrest C.B. Assessment of children's health related quality of life in the United States with a multidimensional index. Pediatrics. 2008; 121 (1): 118–126.Simon A.E., Chan K.S., Forrest C.B. Assessment of children's health related quality of life in the United States with a multidimensional index. Pediatrics. 2008; 121 (1): 118–126.Borres M.P., Brakenhielm G., Irander K. How many teenagers think they have allergic rhinoconjunctivitis and what they do about it. Ann. Allergy Asthma Immunol. 1997; 78: 29–34.Borres M.P., Brakenhielm G., Irander K. How many teenagers think they have allergic rhinoconjunctivitis and what they do about it. Ann. Allergy Asthma Immunol. 1997; 78: 29–34.Arriahi H.M.. Cook C.K., Redding G.J. The prevalence and impact of allergic rhinitis among teenagers. J. Allergy Clin. Immunol. 1996; 97: 430.Arriahi H.M.. Cook C.K., Redding G.J. The prevalence and impact of allergic rhinitis among teenagers. J. Allergy Clin. Immunol. 1996; 97: 430.Bousquet J., Khaltaev N., Cruz A.A. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy. 2008; 63 (86): 8–160Bousquet J., Khaltaev N., Cruz A.A. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy. 2008; 63 (86): 8–160Harvey R.P., Comer C., Sanders B. et al. Model for outcomes assessment of antihistamine use for seasonal allergic rhinitis. J. Allergy Clin. Immunol. 1996; 97 (6): 1233–1241.Harvey R.P., Comer C., Sanders B. et al. Model for outcomes assessment of antihistamine use for seasonal allergic rhinitis. J. Allergy Clin. Immunol. 1996; 97 (6): 1233–1241.De Blic J., Wahn U., Billard E. et al. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. Pediatr. Allergy Immunol. 2005; 16 (3): 267–275.De Blic J., Wahn U., Billard E. et al. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. Pediatr. Allergy Immunol. 2005; 16 (3): 267–275.Corren J., Storms W., Bernstein J. et al. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis. Clin. Ther. 2005; 27 (5): 543–553.Corren J., Storms W., Bernstein J. et al. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis. Clin. Ther. 2005; 27 (5): 543–553.Fokkens W.J., Jogi R., Reinartz S. et al. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy. 2007; 62 (9): 1078–1084.Fokkens W.J., Jogi R., Reinartz S. et al. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy. 2007; 62 (9): 1078–1084.Röder E., Berger M.Y., Hop W.C. et al. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care. J. Allergy Clin. Immunol. 2007; 119 (4): 892–898.Röder E., Berger M.Y., Hop W.C. et al. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care. J. Allergy Clin. Immunol. 2007; 119 (4): 892–898.Piñeyro–López A., Pineyro–Garza E., Torres–Alanís O. et al. Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open label, randomized, two-period crossover comparison in healthy Mexican adult volunteers. Clin. Ther. 2006; 28 (1): 110–115.Piñeyro–López A., Pineyro–Garza E., Torres–Alanís O. et al. Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open label, randomized, two-period crossover comparison in healthy Mexican adult volunteers. Clin. Ther. 2006; 28 (1): 110–115.Guest J.F., Clegg J.P., Smith A.F. Health economic impact of olopatadine compared to branded and generic sodium cromoglycate in the treatment of seasonal allergic conjunctivitis in the UK. Curr. Med. Res. Opin. 2006; 22 (9): 1777–1785.Guest J.F., Clegg J.P., Smith A.F. Health economic impact of olopatadine compared to branded and generic sodium cromoglycate in the treatment of seasonal allergic conjunctivitis in the UK. Curr. Med. Res. Opin. 2006; 22 (9): 1777–1785.Мадьяр К. «Рандомизированное перекрестное исследование биоэквивалентности однократной дозы препаратов Парлазин и Зиртек таблетки, на здоровых мужчинах_добровольцах» Научное досье компании Эгис. Будапешт. Венгрия. 2000.Мадьяр К. «Рандомизированное перекрестное исследование биоэквивалентности однократной дозы препаратов Парлазин и Зиртек таблетки, на здоровых мужчинах_добровольцах» Научное досье компании Эгис. Будапешт. Венгрия. 2000.Ревякина В.А., Кувшинова Е.Д., Сенцова Т.Б. Оценка эффективности антигистаминного препарата лоратадин у детей с сезонным аллергическим ринитом. Вопросы современной педиатрии. 2007; 6 (2): 115–118.Ревякина В.А., Кувшинова Е.Д., Сенцова Т.Б. Оценка эффективности антигистаминного препарата лоратадин у детей с сезонным аллергическим ринитом. Вопросы современной педиатрии. 2007; 6 (2): 115–118.Макарова И.В., Жиглинская О.В., Михайлова Е.А. и др. Сравнительная эффективность препаратов цетиризина дженерика (производство Эгис, Венгрия) и оригинального в форме капель в комплексной терапии атопического дерматита у детей раннего возраста. Вопросы современной педиатрии. 2007; 6 (3): 85–88.Макарова И.В., Жиглинская О.В., Михайлова Е.А. и др. Сравнительная эффективность препаратов цетиризина дженерика (производство Эгис, Венгрия) и оригинального в форме капель в комплексной терапии атопического дерматита у детей раннего возраста. Вопросы современной педиатрии. 2007; 6 (3): 85–88.Iikura Y., Naspitz C., Mikawa H. et al. Prevention of asthma by ketotifen in infants with atopic dermatitis. Ann. Allergy. 1992; 68 (3): 233–236.Iikura Y., Naspitz C., Mikawa H. et al. Prevention of asthma by ketotifen in infants with atopic dermatitis. Ann. Allergy. 1992; 68 (3): 233–236.Bustos G., Bustos D., Bustos G. et al. Prevention of asthma with ketotifen in preasthmatic children: a three-year follow-up study. Clin. Exp. Allergy. 1995; 25 (6): 568–573.Bustos G., Bustos D., Bustos G. et al. Prevention of asthma with ketotifen in preasthmatic children: a three-year follow-up study. Clin. Exp. Allergy. 1995; 25 (6): 568–573.Warner J.O.; ETAC Study Group. A double blinded, randomized, placebo controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months treatment and 18 months' post treatment follow up. J. Allergy Clin. Immunol. 2001; 108 (6): 929-937.Warner J.O.; ETAC Study Group. A double blinded, randomized, placebo controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months treatment and 18 months' post treatment follow up. J. Allergy Clin. Immunol. 2001; 108 (6): 929-937.Fuhlbrigge A., Adams R. The effect of treatment of allergic rhinitis on asthma morbidity, including emergency department visits. Curr. Opin. Allergy Clin. Immunol. 2003; 3 (1): 29–32.Fuhlbrigge A., Adams R. The effect of treatment of allergic rhinitis on asthma morbidity, including emergency department visits. Curr. Opin. Allergy Clin. Immunol. 2003; 3 (1): 29–32.Bousquet J., Gaugris S., Kocevar V. et al. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy. Clin. Exp. Allergy. 2005; 35 (6): 723–727.Bousquet J., Gaugris S., Kocevar V. et al. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy. Clin. Exp. Allergy. 2005; 35 (6): 723–727.Marogna M., Spadolini I., Massolo A. et al. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real life: clinical efficacy and more. Allergy. 2004; 59 (11): 1205–1210.Marogna M., Spadolini I., Massolo A. et al. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real life: clinical efficacy and more. Allergy. 2004; 59 (11): 1205–1210.Сватко Л.Г., Маланичева Т.Г., Рафаилов В.В. и др. Эпидемиология и особенности течения аллергического ринита у детей. Вестн. оториноларингол. 2004; 4: 7–8.Сватко Л.Г., Маланичева Т.Г., Рафаилов В.В. и др. Эпидемиология и особенности течения аллергического ринита у детей. Вестн. оториноларингол. 2004; 4: 7–8.Morais-Almeida M., Gaspar A., Pires G. et al. Risk factors for asthma symptoms at school age: an 8 year prospective study. Allergy Asthma Proc. 2007; 28 (2): 183–189.Morais-Almeida M., Gaspar A., Pires G. et al. Risk factors for asthma symptoms at school age: an 8 year prospective study. Allergy Asthma Proc. 2007; 28 (2): 183–189.
The authors declare that there are no conflicts of interest present.